Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.

Sponsorship: Partisan Bill (Republican 2)

Status: (Introduced) 2026-06-08 - Referred to the House Committee on Energy and Commerce. [HB9190 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
No bill text drafts for US Congress HB9190 currently on file.

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress HB9190

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress HB9190 currently on file.